Biopharmaceutical Purification
Biopharmaceutical Innovation. Pure and Simple.
The biopharmaceutical industry is under tremendous pressure to bring new biologic drugs from clinic to market with lower manufacturing costs. 3M scientists and engineers are devoted to increasing the number and availability of new life-saving therapies.
Designed for upstream and downstream processing within pharmaceutical manufacturing, 3M solutions work to optimise your processes by applying our biopharma experience, material science and proprietary technologies to help you develop highly effective purification solutions. These solutions utilise innovative 3M technologies for the development and manufacturing of recombinant proteins, including monoclonal antibodies (mAbs), vaccines, and therapeutic plasma proteins.
Biopharmaceutical Applications
-
At 3M, we're advancing the recombinant protein industry by helping build better, more efficient manufacturing processes. We are developing solutions to simplify the process and to enhance biologic drug recovery that leads to improved process economics.
-
Our products and solutions help design and develop manufacturing processes for recombinant proteins including mAbs, vaccines and therapeutic plasma proteins. These products are designed for impurity removal in harvest, clarification and downstream polishing which help to maximize upstream and downstream purity, leading to overall improved process economics.
-
3M has been servicing the plasma fractionation industry for more than 30 years. We offer a range of products including depth filters, chromatography products and membrane products, all of which are supported by our validation services offering.
-
3M offers a wide range of adsorptive depth filters and membrane products for application in the chemical pharmaceutical industry. These products may be used for a range of applications including catalyst removal and recovery, color removal, particulate filtration and fill-finish.
Need help streamlining your process?
Our experts will work with you to help find the optimal 3M purification solution for your application and to test our products within your process. We also provide trial data when we work with you to demonstrate product in-use.
Industry News
Discover insights from industry leaders on the latest trends in bioprocessing. Learn about innovations for optimisation of continuous manufacturing, changes in manufacturing landscapes from biosimilars, and new emerging markets such as cell and gene therapies.
-
Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification -
Frost & Sullivan: Perspective on Next Generation Harvest Techniques -
Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalise on Growth Opportunities in High-Value Low-Volume Biologics -
BioProcess Int'l: Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification -
Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology -
Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies -
Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives -
Frost & Sullivan: Commercialisation Strategies in Global Biosimilars Industry
